Houston Methodist. Leading Medicine.
Houston Methodist. Leading Medicine

Center for Liver Disease & Transplantation

Our Physicians

Dr. Victor Ankoma-Sey

Victor Ankoma-Sey, MD, AGAF
Director, Liver Transplant Program at Houston Methodist J.C. Walter Jr. Transplant Center

Victor Ankoma-Sey, MD, AGAF
Director, Liver Transplant Program at Houston Methodist J.C. Walter Jr. Transplant Center

 

Clinical Expertise

  • Hepatology
  • Liver Transplantation
  • Gastroenterology

Selected Professional Activity

  • Board certified in internal medicine, gastroenterology and transplant hepatology
  • American Gastroenterological Association Fellow
  • Member, Development Committee, American Association for the Study of Liver Diseases

Research Interest

  • Liver diseases
  • Clinical trials in antiviral therapy for treatment of Hepatitis B and C
  • Fatty liver
  • Primary biliary cirrhosis
  • Hepatocellular carcinoma
  • Liver transplantation

Education

  • Internal Medicine Residency – Good Samaritan Hospital, Johns Hopkins affiliate, Baltimore
  • Gastroenterology/Hepatology Fellowship (Research Track) – University of California San Francisco
  • University of Ghana Medical School – MD Korle-Bu, Teaching Hospital, Accra, Ghana

Dr. Ankoma-Sey's Biography

Victor Ankoma-Sey is director of the Liver Transplant Program at Houston Methodist Hospital and of the Liver Associates of Texas, PA. He obtained his MD degree from the University of Ghana Medical School and completed his medical internship and residency at the Johns Hopkins affiliate program at the Good Samaritan Hospital in Baltimore, Md. Dr. Ankoma-Sey completed his gastroenterology and hepatology fellowship training at the University of California, San Francisco, and he is a fellow of the American Gastroenterological Association.

Dr. Ankoma-Sey is board certified in internal medicine, gastroenterology and transplant hepatology. In 2002, he founded the private practice, Liver Associates of Texas, PA. His clinical interests focus on the optimal management of patients with chronic viral hepatitis B and C, fatty liver, liver tumors, cirrhosis, advanced liver disease, liver transplantation and maintaining liver health. His research interests are focused on clinical therapeutic trials in antiviral therapy for treatment of hepatitis B and C, fatty liver and primary biliary cirrhosis, surveillance and tumor markers in liver cancer.

Dr. Ankoma-Sey has published more than 100 original papers, review articles and abstracts and has received various prestigious awards in his field. He is also a member of numerous medical associations and serves as an AASLD Development Committee member.